About Organon & Co. 
Organon & Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 103 Schemes (45.63%)
Foreign Institutions
Held by 221 Foreign Institutions (11.14%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,602 Million
(Quarterly Results - Sep 2025)
Net Profit:
160 Million
Pharmaceuticals & Biotechnology
USD 2,493 Million (Small Cap)
3.00
NA
0.62%
9.00
63.13%
2.75






